During the past decade, AGA Clinical Trials conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 19 clinical trials were completed, i.e. on average, 86.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 11 clinical trials were completed. i.e. 122.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AGA Clinical Trials" #1 sponsor was "Pfizer" with 6 trials, followed by "Gilead Sciences" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "H. Lundbeck A/S" with 3 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AGA Clinical Trials" #1 collaborator was "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Cyclerion Therapeutics" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator and "Veristat, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "AGA Clinical Trials" are "Influenza" (3 trials), "Migraine" (3 trials), "Migraine, With or Without Aura" (3 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Hypertension" (2 trials). Many other conditions were trialed in "AGA Clinical Trials" in a lesser frequency.

Most popular intervention types in "AGA Clinical Trials" are "Drug" (36 trials), "Biological" (4 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Eptinezumab" (3 trials), "Rimegepant" (3 trials), "Darusentan" (2 trials) and "Diet" (2 trials). Other intervention names were less common.

The vast majority of trials in "AGA Clinical Trials" are 39 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "AGA Clinical Trials". 1 are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in AGA Clinical Trials, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in AGA Clinical Trials, 6 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".